ArticleBMC bioinformatics2026
Frag'n'Flow: automated workflow for large-scale quantitative proteomics in high performance computing environments.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAnalysing large-scale mass spectrometry-based complex proteomics datasets often overwhelm desktop computational resources and require manual configuration for analysis. While FragPipe delivers rapid peptide identification across diverse sample preparation and acquisition modes (DDA, DIA, TMT), it remains challenging to deploy at scale.
resultsWe introduce Frag’n’Flow, a Nextflow‐based pipeline that encapsulates FragPipe, automates input manifest and workflow generation, manages tool dependencies and includes downstream data analysis options to enable reproducible, high‐performance analyses on HPC, cloud, and cluster environments. Benchmarking against other workflow-based solutions shows that our pipeline maintains quantitative accuracy and cuts runtime nearly in half on a typical DIA dataset of ~ 58 GB, while alleviating memory and I/O bottlenecks. We validate Frag’n’Flow results across three representative datasets, label-free DDA, DIA, and TMT, successfully recapitulating published biological signatures with minimal user intervention.
conclusionsBy combining the sensitivity and speed of FragPipe with Nextflow’s orchestration, Frag’n’Flow enables the analysis of large‐scale proteomics data, empowering the scientific community, without extensive computation expertise, to extract new insights from existing MS datasets. Frag’n’Flow is available at: https://github.com/ronalabrcns/FragNFlow .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.